Anaptysbio Balance Sheet (2016-2026)

Reported Financials

Anaptysbio Quarterly Balance Sheet

Periods 38 quarters

Latest Mar 2026

Anaptysbio reported total assets of $329.68M and total liabilities of $316.94M for the quarter ended Mar 2026, down 21.9% year over year. This balance sheet covers 38 quarters of results from Dec 2016 through Mar 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.	332.25M	336.33M	495.73M	166.41M	71.70M	58.55M	71.31M	94.56M	35.21M	26.30M	35.97M	53.70M	71.82M	191.58M	123.08M	98.64M	44.30M	109.83M	238.20M	248.47M
Short-term InvestmentsInvestments (Current)	58.60M	37.74M	52.37M	339.21M	370.45M	384.42M	369.93M	336.59M	394.28M	386.75M	354.94M	300.97M	278.98M	238.54M	262.29M	241.30M	221.41M	139.12M	73.44M	37.99M
Cash & Current Investments	390.85M	374.06M	548.10M	505.62M	442.15M	442.97M	441.24M	431.15M	429.49M	413.05M	390.90M	354.67M	350.80M	430.12M	385.37M	339.94M	265.71M	248.96M	311.64M	286.45M
Receivables - NetNet Receivables	0.64M	0.76M	0.88M	0.92M	1.03M	1.18M	1.42M	1.52M	3.18M	3.27M	6.85M	7.09M	9.01M	12.20M	40.77M	17.88M	21.42M	75.69M	33.85M	25.75M
Receivables - OtherOther Receivables
Receivables	0.64M	0.76M	0.88M	0.92M	1.03M	1.18M	1.42M	1.52M	3.18M	3.27M	6.85M	7.09M	9.01M	12.20M	40.77M	17.88M	21.42M	75.69M	33.85M	25.75M
Prepaid Assets	6.51M	11.76M	4.90M	5.87M	9.62M	6.30M	4.54M	4.48M	5.87M	11.68M	9.08M	10.67M	7.54M	6.37M	5.74M	5.29M	4.78M	6.01M	4.76M	3.91M
Current Assets	398.06M	386.64M	553.88M	512.41M	452.81M	450.44M	447.20M	437.15M	438.54M	428.00M	406.83M	372.42M	367.35M	448.68M	431.88M	363.11M	291.91M	330.65M	350.25M	316.11M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)	2.49M	2.41M	2.28M	2.16M	2.06M	1.97M	2.09M	1.98M	2.02M	2.25M	2.10M	1.95M	1.83M	1.73M	1.85M	1.74M	1.63M	1.50M	1.37M	1.28M
Long-Term Investments	5.48M	15.24M	67.10M	91.19M	129.99M	147.51M	142.94M	94.93M	59.24M	40.20M	27.03M	15.47M	42.65M	27.91M	35.47M	43.02M	28.00M	7.70M
Other Non-Current Assets	0.26M	0.26M	0.26M	0.26M	0.26M	0.26M	0.26M	0.26M	0.26M	0.26M	0.26M	0.26M	0.26M	0.26M	0.26M	0.26M	0.26M	0.26M	0.26M	0.26M
Non-Current Assets	28.51M	37.69M	89.19M	112.76M	151.04M	168.06M	163.18M	114.64M	78.56M	59.33M	45.55M	33.41M	60.03M	44.74M	51.96M	58.94M	43.34M	22.45M	14.14M	13.57M
Assets	426.57M	424.33M	643.07M	625.17M	603.85M	618.50M	610.38M	551.79M	517.10M	487.33M	452.39M	405.83M	427.38M	493.42M	483.83M	422.05M	335.25M	353.10M	364.39M	329.68M
Liabilities
Current Liabilities
Accounts Payables	4.10M	5.72M	1.74M	2.48M	1.59M	3.01M	2.78M	3.17M	4.76M	6.52M	4.70M	4.58M	4.89M	3.59M	4.00M	6.12M	3.33M	2.89M	3.87M	7.52M
Notes Payables
Payables	4.10M	5.72M	1.74M	2.48M	1.59M	3.01M	2.78M	3.17M	4.76M	6.52M	4.70M	4.58M	4.89M	3.59M	4.00M	6.12M	3.33M	2.89M	3.87M	7.52M
Accumulated Expenses	15.96M	14.07M	12.85M	15.76M	16.71M	16.45M	21.63M	30.96M	35.16M	30.92M	30.97M	25.90M	33.68M	38.40M	39.50M	35.95M	30.20M	33.17M	32.67M	32.06M
Other Accumulated Expenses															30.21M				16.40M	17.79M
Total Current Liabilities	20.62M	20.89M	16.10M	19.78M	19.87M	21.06M	26.05M	35.80M	41.63M	39.18M	37.44M	32.30M	40.42M	43.88M	45.43M	44.04M	35.53M	38.10M	38.62M	41.70M
Non-Current Liabilities
Non-Current Debt
Preferred Stock Liabilities
Operating Leases	20.22M	19.84M	19.45M	19.06M	18.65M	18.23M	17.81M	17.39M	16.95M	16.49M	16.04M	15.57M	15.10M	14.61M	14.11M	13.61M	13.10M	12.57M	12.03M	11.49M
Other Non-Current Liabilities			251.09M	255.58M	261.02M	301.59M	304.41M	307.52M	310.07M	311.27M	310.81M	310.18M	361.98M	350.56M	353.43M	330.38M	331.36M	331.84M	276.53M	263.74M
Total Non-Current Liabilities			35.55M	38.84M	38.52M	39.30M	43.87M	53.18M	58.58M	55.67M	53.48M	47.87M	55.52M	58.49M	59.54M	57.65M	48.62M	50.67M	50.66M	53.20M
Total Liabilities	40.84M	40.73M	286.64M	294.42M	299.54M	340.88M	348.28M	360.70M	368.65M	366.94M	364.29M	358.06M	417.50M	409.05M	412.97M	388.03M	379.98M	382.51M	327.19M	316.94M
Shareholder's Equity
Total Debt
Common Equity	385.73M	383.61M	356.43M	330.75M	304.31M	277.62M	262.10M	191.09M	148.45M	120.38M	88.10M	47.78M	9.88M	84.37M	70.87M	34.02M	-44.73M	-29.42M	37.21M	12.75M
Liabilities and Shareholders Equity	426.57M	424.33M	643.07M	625.17M	603.85M	618.50M	610.38M	551.79M	517.10M	487.33M	452.39M	405.83M	427.38M	493.42M	483.83M	422.05M	335.25M	353.10M	364.39M	329.68M
Retained Earnings	-282.55M	-289.21M	-321.75M	-358.01M	-390.56M	-424.06M	-450.48M	-494.73M	-534.58M	-571.88M	-614.10M	-658.03M	-704.69M	-737.54M	-759.33M	-798.66M	-837.29M	-822.17M	-772.56M	-825.44M

Anaptysbio Balance Sheet API

Pull Anaptysbio's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ANAB&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY

import requests

url = "https://data.businessquant.com/statements"
params = {"ticker": "ANAB", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}

data = requests.get(url, params=params).json()

const res = await fetch("https://data.businessquant.com/statements?ticker=ANAB&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();

API documentation

Anaptysbio ANAB Balance Sheet (2016-2026)

Anaptysbio Quarterly Balance Sheet

Anaptysbio Balance Sheet API

Create an account

Sign In

Reset Password